EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrated Omics Insights into Dapagliflozin Effects in Sepsis-Induced Cardiomyopathy

Weiwei Lai iD, Li Liu, Shuhang Wang, Yancun Liu iD, Yanfen Chai

Biomolecules · 14.02.2025 · 15 (2) · 286

DOI: 10.3390/biom15020286 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, online erschienen am 14.02.2025. Verfasst von Weiwei Lai und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, Tianjin Medical University General Hospital, Tianjin 300052, China. Hauptthemen laut MEDLINE: Glucosides, Benzhydryl Compounds, Sepsis, Cardiomyopathies. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tianjin Key Medical Discipline(Specialty) Construction Project, National Natural Science Foundation of China, Natural Science Foundation of Tianjin.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sepsis-induced cardiomyopathy (SIC) is a life-threatening cardiac complication of sepsis with limited therapeutic options. Dapagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, has demonstrated cardioprotective effects in heart failure, but its role in mitigating sepsis-related cardiac dysfunction remains unclear.

Methods

A retrospective cohort analysis was conducted to assess the impact of pre-hospital dapagliflozin use on major adverse cardiovascular events (MACEs) and survival in patients with SIC. Additionally, a murine SIC model was established using cecal ligation and puncture (CLP) to evaluate the effects of dapagliflozin on cardiac function, histopathology, and biomarkers of myocardial injury. Transcriptomic and metabolomic profiling, combined with multi-omics integration, was employed to elucidate the molecular mechanisms underlying dapagliflozin’s cardioprotective effects.

Results

In the clinical cohort, pre-hospital dapagliflozin use was associated with a significant reduction in the risk of MACE and improved survival outcomes. In the murine SIC model, dapagliflozin restored cardiac function, reduced biomarkers of myocardial injury, and alleviated histological damage. Multi-omics analysis revealed that dapagliflozin modulates inflammatory responses, enhances autophagy, and regulates metabolic pathways such as AMPK signaling and lipid metabolism. Key regulatory genes and metabolites were identified, providing mechanistic insights into the underlying actions of dapagliflozin.

Conclusions

Dapagliflozin significantly improves cardiac outcomes in sepsis-induced cardiomyopathy through the multi-level regulation of inflammation, energy metabolism, and cellular survival pathways. These findings establish dapagliflozin as a promising therapeutic strategy for SIC, offering translational insights into the treatment of sepsis-induced cardiac dysfunction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlucosidesBenzhydryl CompoundsSepsisCardiomyopathiesSodium-Glucose Transporter 2 InhibitorsAnimalsMiceHumansMaleMetabolomicsRetrospective StudiesDisease Models, AnimalMice, Inbred C57BLFemale

Stichwörter der Autor:innen

cardioprotective mechanismsdapagliflozinmetabolomicssepsis-induced cardiomyopathytranscriptomics

Substanzen

GlucosidesBenzhydryl CompoundsdapagliflozinSodium-Glucose Transporter 2 Inhibitors

Autor:innen und Institutionen

  • Department of Emergency Medicine, Tianjin Medical University General Hospital, Tianjin 300052, China.

ORCID-Profile: Weiwei Lai, Yancun Liu

Förderung

  • Tianjin Key Medical Discipline(Specialty) Construction Project
  • National Natural Science Foundation of China
  • Natural Science Foundation of Tianjin

Zitieren

APA

Lai, W., Liu, L., Wang, S., Liu, Y., & Chai, Y. (2025). Integrated Omics Insights into Dapagliflozin Effects in Sepsis-Induced Cardiomyopathy. Biomolecules, 15(2), 286. https://doi.org/10.3390/biom15020286

Vancouver

Lai W, Liu L, Wang S, Liu Y, Chai Y. Integrated Omics Insights into Dapagliflozin Effects in Sepsis-Induced Cardiomyopathy. Biomolecules. 2025;15(2):286. doi:10.3390/biom15020286

BibTeX
@article{Lai2025,
  author = {Lai, Weiwei and Liu, Li and Wang, Shuhang and Liu, Yancun and Chai, Yanfen},
  title = {Integrated Omics Insights into Dapagliflozin Effects in Sepsis-Induced Cardiomyopathy},
  journal = {Biomolecules},
  year = {2025},
  volume = {15},
  number = {2},
  pages = {286},
  doi = {10.3390/biom15020286}
}
Kostenlos starten →